Preclinical activity of selinexor in combination with eribulin in uterine leiomyosarcoma

Preclinical activity of selinexor in combination with eribulin in uterine leiomyosarcoma

Abstract Leiomyosarcoma (LMS) is a rare soft tissue sarcoma (STS) that begins in smooth muscle tissue and most often initiates in the abdomen or uterus. Compared with other uterine cancers, uterine LMS (ULMS) is an aggressive tumor with poor prognosis and a high risk of recurrence and death, regardl...

Full description

Bibliographic Details
Main Authors: Sonam Mittal, Ishaque Pulikkal Kadamberi, Hua Chang, Feng Wang, Sudhir Kumar, Shirng-Wern Tsaih, Christopher J. Walker, Pradeep Chaluvally-Raghavan, John Charlson, Yosef Landesman, Sunila Pradeep
Format: Article
Language:English
Published: BMC 2023-09-01
Series:Experimental Hematology & Oncology
Subjects:
LMS
ULMS
XPO1
Sarcoma
Eribulin
Selinexor
Online Access:https://doi.org/10.1186/s40164-023-00443-w

Internet

https://doi.org/10.1186/s40164-023-00443-w

Similar Items